Arab Health 2023

Earlier this month, the Department for Business and Trade formally launched the Life Sciences Innovator Showcase at Arab Health. Eight of our showcase companies attended and they established promising relationships with potential investors and collaborators from around the world.

Visit event site

Event overview

Being part of the DIT’s Innovator Showcase at Arab Health was immensely helpful, both in terms of providing a platform for 52North and in enabling us to navigate and maximise business opportunity at one of the world’s largest health conferences in an organised and focused way. We’ve established some excellent relationships and are incredibly excited at the opportunities that have been opened for us that will ultimately enable us to bring Neutrocheck® to cancer patients across the Arab world.
52North

Companies who attended:

52 North Health are developing affordable, patient-centred and fully-integrated clinical, AI and medical-device based systems. Its first product addresses neutropenic sepsis: the most fatal
side-effect of chemotherapy. 

Visit company site

Umaima Ahmad

CEO & Co-Founder

Delivering the world’s first lightweight, portable, cost-effective neonatal Incubator – designed to be used anywhere and everywhere. 

Visit company site

James Roberts

Founder & CEO

CanCertain uses advanced 3D cell culture techniques to identify the most effective cancer treatment for each individual patient within just
8 days.

Visit company site

Dharmesh Mehta

Business Development Director

Developing and launching industry-leading solutions across Trauma, Haemostasis, Obstetrics and Wound care sectors. 

Visit company site

Andy Sutcliffe

Global Strategic Marketing Director

Developing non-invasive neurostimulation devices that treat a range neurological and metabolic disease by applying electrical stimulation to the deep parts of the brain. 

Visit company site

Jason McKeown

CEO

Sonrai's digital analytics suite allows researchers access to cutting-edge AI tools to help pharma and biotech companies discover the next generation of biomarkers. 

Visit company site

Darragh McArt

CEO

Through its patented mechanism of non-invasive neuromuscular electrostimulation, Sky has developed a technology platform, OnPulse™, embedded in its industry-leading product, the
geko™ device. 

Visit company site

Bernard Ross

Founder & CEO

Sonrai's digital analytics suite allows researchers access to cutting-edge AI tools to help pharma and biotech companies discover the next generation of biomarkers. 

Visit company site

Dr Vibhor Gupta

Director & Founder

From the event:

While at Arab Health, Minister Bowie had the chance to interview Founder & CEO of mOm Incubators, James Roberts. Click the link below to watch the interview.

Watch interview
Arab Health brings together regional and international partners and businesses focused at delivering all aspect of healthcare. DIT had provided Phaim Pharma, along with its other Showcase Innovators a literal and virtual platform to meet, connect and collaborate. The whole team was on hand to facilitate workshops, roundtable discussions and to support introductions between potential collaborators. DIT provided fantastic support and Phaim benefited from their knowledge and expert guidance.
Nara Daubeney, COO & Co-Founder of Phaim Pharma
As a Life Science Innovation Showcase finalist, DIT provided a significant opportunity for us to increase awareness for CELOX PPH™, a unique and ground-breaking British innovation to help address the leading cause of maternal mortality worldwide, through engagement with medical experts across key global markets, introductions with new sales channels and the opportunity to engage in networking events and presentations to audience representation from around the world. The global interest in this product has been unprecedented and DIT have played a significant part in raising our profile during this year’s Arab Health event.
Andy Sutcliffe, Global Strategic Marketing Director of Medtrade